 |
PDBsum entry 3qd3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3qd3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 1,1- dimethylethyl {(3r,6s)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4- pyrimidinyl]-6-methyl-3-piperidinyl}carbamate
|
|
Structure:
|
 |
3-phosphoinositide-dependent protein kinase 1. Chain: a. Fragment: kinase domain, residues 48-359. Synonym: hpdk1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: pdk1, pdpk1. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108
|
|
Resolution:
|
 |
|
2.00Å
|
R-factor:
|
0.185
|
R-free:
|
0.211
|
|
|
Authors:
|
 |
J.R.Medina,C.J.Becker,C.W.Blackledge,C.Duquenne,Y.Feng,S.W.Grant, D.Heerding,W.H.Li,W.H.Miller,S.P.Romeril,D.Scherzer,A.Shu,M.A.Bobko, A.R.Chadderton,M.Dumble,C.M.Gradiner,S.Gilbert,Q.Liu,S.K.Rabindran, V.Sudakin,H.Xiang,P.G.Brady,N.Campobasso,P.Ward,J.M.Axten
|
|
Key ref:
|
 |
J.R.Medina
et al.
(2011).
Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors.
J Med Chem,
54,
1871-1895.
PubMed id:
|
 |
|
Date:
|
 |
|
17-Jan-11
|
Release date:
|
09-Mar-11
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O15530
(PDPK1_HUMAN) -
3-phosphoinositide-dependent protein kinase 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
556 a.a.
279 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Med Chem
54:1871-1895
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors.
|
|
J.R.Medina,
C.J.Becker,
C.W.Blackledge,
C.Duquenne,
Y.Feng,
S.W.Grant,
D.Heerding,
W.H.Li,
W.H.Miller,
S.P.Romeril,
D.Scherzer,
A.Shu,
M.A.Bobko,
A.R.Chadderton,
M.Dumble,
C.M.Gardiner,
S.Gilbert,
Q.Liu,
S.K.Rabindran,
V.Sudakin,
H.Xiang,
P.G.Brady,
N.Campobasso,
P.Ward,
J.M.Axten.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |